drug: nalmefene

*

• Clinical class: opioid reversal
• Chemical class: synthetic opioid
• Action: opioid antagonist
• DEA schedule: none
• Route of administration: parenteral
• Also: nalmetrene

U.S. Preparations:

• Revex^® (Baxter) FDA approved for treatment of:
  4.17.1995 complete or partial reversal of opioid drug effects, including respiratory depression, induced by either natural or synthetic opioids
  7.9.2008 production discontinued
  U.S. Prescribing information

International Preparations:

• Arthene^®, Cervene^®, Fenarc^®, Incystene^®

*Molecule graphic courtesy of Steve Chapman

http://www.behavenet.com/capsules
Search Capsules™ | Terms of Use | Request New Term
Capsules™ Copyright © 1997-2009 BehaveNet®